Stephens Starts Cytek Biosciences Inc (CTKB) at Overweight, 'Pure Play Cell Analysis Co. With Differentiated Tech/Operating Profile'
Tweet Send to a Friend
(Updated - December 13, 2023 4:23 PM EST)
Stephens analyst Mason Carrico initiates coverage on Cytek Biosciences Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stephens analyst Mason Carrico initiates coverage on Cytek Biosciences Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
